@article{8ed2c981c41a4e939ca25563712f7ed3,
title = "Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts",
keywords = "Small cell lung cancer (SCLC), Second-line chemotherapy, Decision making, Objective consensus, OPEN-LABEL, PHASE-III, TOPOTECAN, CHEMOTHERAPY, MULTICENTER, RECHALLENGE, ETOPOSIDE, SELECTION, OUTCOMES, IASLC",
author = "M. Frueh and Panje, {C. M.} and M. Reck and F. Blackhall and R. Califano and F. Cappuzzo and B. Besse and S. Novello and P. Garrido and E. Felip and M. O'Brien and Ares, {L. Paz} and {de Marinis}, F. and Virginie Westeel and {De Ruysscher}, D. and Putora, {P. M.}",
year = "2020",
month = aug,
doi = "10.1016/j.lungcan.2020.03.024",
language = "English",
volume = "146",
pages = "6--11",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
}